Monobenzone for Vitiligo Treatment — Complete Medical Guide

Monobenzone for Vitiligo — Introduction

Monobenzone (MBEH) is the most potent and only FDA-approved treatment for permanent depigmentation in vitiligo patients. For the right patient — typically with extensive vitiligo affecting more than 50% of body surface — monobenzone therapy can provide dramatic improvement in quality of life by achieving a uniform skin tone.

Who is a Candidate for Monobenzone Vitiligo Treatment?

Monobenzone depigmentation therapy is appropriate for:

• Patients with vitiligo affecting more than 50% of body surface area
• Patients for whom repigmentation therapy (steroids, tacrolimus, NB-UVB, PUVA) has failed
• Patients who have made an informed decision about permanent depigmentation
• Cases supervised by a qualified dermatologist
• Patients who understand and accept the permanent nature of the treatment

Why Monobenzone is the Treatment of Choice for Extensive Vitiligo

• Only FDA-approved treatment for vitiligo depigmentation since 1952
• Most potent depigmenting agent available — clinically proven
• Topical cream — easy home application, no hospital visits
• Permanent results — no maintenance treatment needed after depigmentation
• Proven psychosocial benefit — studies show significant quality of life improvement

Monobenzone Vitiligo Treatment Protocol

Step 1 — Dermatologist assessment: Confirm vitiligo extent and patient suitability for depigmentation

Step 2 — Start monobenzone 20%: Apply twice daily to pigmented areas, avoiding vitiligo patches

Step 3 — Monitor response: Assess skin tolerance and depigmentation progress at 4–8 weeks

Step 4 — Escalate if needed: Progress to monobenzone 40% for faster results if 20% is well-tolerated

Step 5 — Maintenance: Once depigmentation is complete, apply SPF 50+ sunscreen daily for life

Clinical Evidence for Monobenzone in Vitiligo

A peer-reviewed study (PMCID: PMC3533321) in the Journal of Clinical and Aesthetic Dermatology documented:

• Excellent depigmentation results with monobenzone 20% cream in extensive vitiligo
• Extremely satisfactory results within 3.5 months of twice-daily application
• Sustained permanent depigmentation confirmed at 3-year follow-up
• Significant improvement in patient quality of life